Document type
ArticleVersion
Accepted versionPublication date
All rights reserved
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/144560
Treating HIV-Positive/Non-AIDS Patients for Community-Acquired Pneumonia with ART
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
Purpose of Review: This article reviews the most recent publications on community-acquired pneumonia (CAP) in the HIV-infected population on antiretroviral therapy (ART), focusing on epidemiology, prognostic factors, etiology, and antimicrobial therapy. The data discussed here were mainly obtained from a non-systematic review using Medline and references from relevant articles. Recent Findings: CAP remains a major cause of morbidity and mortality among HIV-infected patients and incurs high health costs despite the introduction of ART. Summary: HIV-infected patients are generally known to be more susceptible to bacterial pneumonia. Streptococcus pneumoniae is the most frequently reported pathogen in HIV-infected patients on ART, who present a higher rate of bacteremia than non-HIV-infected patients. Several studies have also examined microbial etiology and prognostic factors of CAP in HIV-infected patients on ART. Despite the high rate of bacterial pneumonia in these patients, mortality rates are not higher than in patients without HIV infection.
Subject (English)
Citation
Citation
CILLÓNIZ, Catia, IELPO, Antonella and TORRES MARTÍ, Antoni. Treating HIV-Positive/Non-AIDS Patients for Community-Acquired Pneumonia with ART. Current Infectious Disease Reports. 2018. Vol. 20, num. 46. ISSN 1523-3847. [consulted: 8 of June of 2026]. Available at: https://hdl.handle.net/2445/144560